Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracanal Medicaments for Periapical Lesion Healing
NCT06342830Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2024
- Primary completion
- Sep 2025
- Modality
- Nanoparticles, Nucleic Acid-Directed Small Molecules, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nanocurcumin gel, curcumin, ciprofloxacin + ibuprofen gel, ibuprofen in apical periodontitis (AP), sponsored by Ain Shams University. Started Jun 2024; status: completed.
02
Drugs
nanocurcumin gelcurcuminciprofloxacin + ibuprofen gelibuprofen
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT06342830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06342830.